Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Net Income towards Common Stockholders (2019 - 2025)

Historic Net Income towards Common Stockholders for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$9.1 million.

  • Biodesix's Net Income towards Common Stockholders rose 1417.42% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 824.26%. This contributed to the annual value of -$42.8 million for FY2024, which is 1596.37% up from last year.
  • Per Biodesix's latest filing, its Net Income towards Common Stockholders stood at -$9.1 million for Q3 2025, which was up 1417.42% from -$11.6 million recorded in Q2 2025.
  • Biodesix's Net Income towards Common Stockholders' 5-year high stood at -$6.2 million during Q1 2021, with a 5-year trough of -$18.8 million in Q1 2023.
  • Over the past 5 years, Biodesix's median Net Income towards Common Stockholders value was -$11.6 million (recorded in 2025), while the average stood at -$12.1 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 29234.66% in 2021, then surged by 4404.5% in 2023.
  • Biodesix's Net Income towards Common Stockholders (Quarter) stood at -$13.2 million in 2021, then decreased by 24.78% to -$16.4 million in 2022, then skyrocketed by 44.05% to -$9.2 million in 2023, then rose by 8.67% to -$8.4 million in 2024, then dropped by 8.62% to -$9.1 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$9.1 million for Q3 2025, versus -$11.6 million for Q2 2025 and -$10.8 million for Q1 2025.